Haemonetics (HAE)
(Delayed Data from NYSE)
$91.42 USD
-0.16 (-0.17%)
Updated Jul 24, 2024 04:00 PM ET
After-Market: $91.41 -0.01 (-0.01%) 7:58 PM ET
2-Buy of 5 2
B Value B Growth F Momentum B VGM
Detailed Estimates
EPS Estimates
Earnings Date | *BMO8/8/24 |
---|---|
Current Quarter | 1.03 |
EPS Last Quarter | 0.90 |
Last EPS Surprise | 2.27% |
ABR | 1.67 |
Earnings ESP
|
0.00% |
---|---|
Current Year | 4.57 |
Next Year | 5.12 |
EPS (TTM) | 3.98 |
P/E (F1) | 20.04 |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (3/2025) |
Next Year (3/2026) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 335.87M | 346.17M | 1.39B | 1.44B |
# of Estimates | 3 | 3 | 3 | 3 |
High Estimate | 345.21M | 348.62M | 1.40B | 1.46B |
Low Estimate | 329.17M | 343.51M | 1.38B | 1.43B |
Year ago Sales | 311.33M | 318.18M | 1.31B | 1.39B |
Year over Year Growth Est. | 7.88% | 8.80% | 6.43% | 3.16% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (3/2025) |
Next Year (3/2026) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 1.03 | 1.11 | 4.57 | 5.12 |
# of Estimates | 3 | 3 | 3 | 3 |
Most Recent Consensus | 1.02 | 1.10 | 4.51 | 5.00 |
High Estimate | 1.04 | 1.12 | 4.60 | 5.25 |
Low Estimate | 1.02 | 1.10 | 4.51 | 5.00 |
Year ago EPS | 1.05 | 0.99 | 3.96 | 4.57 |
Year over Year Growth Est. | -1.90% | 12.12% | 15.40% | 12.11% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (3/2025) |
Next Year (3/2026) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 1 | 1 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (3/2025) |
Next Year (3/2026) |
|
---|---|---|---|---|
Current | 1.03 | 1.11 | 4.57 | 5.12 |
7 Days Ago | 1.03 | 1.11 | 4.57 | 5.12 |
30 Days Ago | 1.03 | 1.11 | 4.57 | 5.12 |
60 Days Ago | 1.02 | 1.10 | 4.55 | 5.11 |
90 Days Ago | 1.01 | 1.06 | 4.24 | 4.87 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (3/2025) |
Next Year (3/2026) |
|
---|---|---|---|---|
Most Accurate Estimate | 1.03 | 1.11 | 4.57 | 5.12 |
Zacks Consensus Estimate | 1.03 | 1.11 | 4.57 | 5.12 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.90 | 1.04 | 0.99 | 1.05 | NA |
Estimate | 0.88 | 0.97 | 0.94 | 0.76 | NA |
Difference | 0.02 | 0.07 | 0.05 | 0.29 | 0.11 |
Surprise | 2.27% | 7.22% | 5.32% | 38.16% | 13.24% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more